Q1 2019

Filed May 14, 2019 · 10-Q · 44 days after period end · 0001493152-19-007082

Q1 2019 · 10-Q

Revenue—

Net Income

-$3.86M

N/M vs Q1 2018

EPS Diluted

-$0.08

N/M vs Q1 2018

Operating Income-$3,997,000N/M

Operating Cash Flow-$6,718,000N/M

Same quarter

Metric	Q1 2019	Q1 2018	Q1 2017	Q1 2016
Revenue	—	—	—	$0.00
Net Income	-$3.86M	-$3.78M	-$4.70M	-$2.93M
EPS Diluted	-$0.08	-$0.12	-$0.16	-$0.12

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR